Differentiating FSO and FSP approaches can better align definitions of models for CROs and sponsors.
Dr. Mark Travers
Advertisement
VP, Head of GCTO Regions and Head Quarters Functions at Merck & Co
Articles by Dr. Mark Travers
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
The Business Case for DEI in Pharmaceutical Innovation: Why Organizational Commitment Matters for Inclusive Clinical Trials
2
Applying AI to Reduce Administrative Burden Without Losing the Human Touch
3
Women as the Missing Voice in Parkinson’s Disease
4
Why Startup Timelines Are Worsening—and How to Reverse the Trend
5